ID: ALA136287

Max Phase: Preclinical

Molecular Formula: C25H19FN6

Molecular Weight: 422.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1nc2ccc(/C(=N/Nc3ccccc3)c3ccccc3)nn2c1-c1ccc(F)cc1

Standard InChI:  InChI=1S/C25H19FN6/c26-19-13-11-18(12-14-19)24-25(27)28-22-16-15-21(31-32(22)24)23(17-7-3-1-4-8-17)30-29-20-9-5-2-6-10-20/h1-16,29H,27H2/b30-23+

Standard InChI Key:  BHSMKMRAPBOHJS-JJKYIXSRSA-N

Associated Targets(non-human)

rhinovirus B14 1052 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Picornaviridae 7 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 422.47Molecular Weight (Monoisotopic): 422.1655AlogP: 4.98#Rotatable Bonds: 5
Polar Surface Area: 80.60Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.05CX LogP: 6.09CX LogD: 6.09
Aromatic Rings: 5Heavy Atoms: 32QED Weighted: 0.31Np Likeness Score: -1.35

References

1. Hamdouchi C, Sanchez-Martinez C, Gruber J, Del Prado M, Lopez J, Rubio A, Heinz BA..  (2003)  Imidazo[1,2-b]pyridazines, novel nucleus with potent and broad spectrum activity against human picornaviruses: design, synthesis, and biological evaluation.,  46  (20): [PMID:13678411] [10.1021/jm020583i]
2. Prado-Prado FJ, Martinez de la Vega O, Uriarte E, Ubeira FM, Chou KC, González-Díaz H..  (2009)  Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.,  17  (2): [PMID:19112024] [10.1016/j.bmc.2008.11.075]

Source